SVV · Savers Value Village, Inc. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-16 | ALLEN WILLIAM T |
Director |
Convert↑
|
Common Stock
|
7,135 |
| 2026-09-16 | ALLEN WILLIAM T |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $9.195 to $9.285. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
26,151 |
| 2026-09-16 | ALLEN WILLIAM T |
Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 28, 2019 stock option grant of which 25% vested upon the initial public offering , 25% vested in June 2024 and the remainder will be eligible for vesting upon satisfaction of certain performance criteria. The total outstanding excludes the portion of the original option grant that was solely time-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
12,402 |
| 2026-09-16 | ALLEN WILLIAM T |
Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 28, 2019 stock option grant vested in substantially equal annual installments over five years starting May 20, 2020, and was fully vested on May 20, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
6,614 |
| 2026-09-16 | ALLEN WILLIAM T |
Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
7,135 |
| 2026-09-16 | ALLEN WILLIAM T |
Director |
Convert↑
|
Common Stock
|
12,402 |
| 2026-09-16 | ALLEN WILLIAM T |
Director |
Convert↑
|
Common Stock
|
6,614 |
| 2026-08-13 | ARES MANAGEMENT LLC |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
Following the transactions reported herein, includes 53,083,382 shares held by Ares Corporate Opportunities Fund V, L.P. ("ACOF V"), 5,435,262 shares held by ASSF IV AIV B Holdings III, L.P. ("ASSF IV AIV Holdings"), 7,945,865 shares held by ASSF IV AIV B, L.P. ("ASSF IV AIV") and 26,223,742 shares held by ASOF Holdings I, L.P. ("ASOF Holdings I"). Also includes 1,760,937 shares (the "Managed Shares") held by an account managed by ASSF Operating Manager IV, L.P. with respect to which the Ares Entities (as defined below) may be deemed to have shared voting or dispositive power. The Ares Entities disclaim beneficial ownership of the Managed Shares for purposes of Section 16 and this report shall not be deemed an admission that any of the Ares Entities are the beneficial owner of the Managed Shares for purposes of Section 16 or for any other purpose. Ares Partners Holdco LLC ("Ares Partners") is the sole member of each of Ares Voting LLC and Ares Management GP LLC, which are respectively the holders of the Class B and Class C common stock of Ares Management Corporation ("Ares Management"), which common stock allows them, collectively, to generally have the majority of the votes on any matter submitted to the stockholders of Ares Management if certain conditions are met. Ares Management is the sole member of Ares Holdco LLC, which is the general partner of Ares Management Holdings L.P., which is the sole member of Ares Management LLC, which is: (i) the sole member of ACOF Investment Management LLC, which is the manager of ACOF V; (ii) the general partner of ASSF Operating Manager IV, L.P., which is the manager of each of ASSF IV AIV Holdings and ASSF IV AIV; and (iii) the sole member of ASOF Investment Management LLC, which is the manager of ASOF Holdings I. We refer to all of the foregoing entities collectively as the Ares Entities Each of the Ares Entities may be deemed to share beneficial ownership of the securities reported herein, but each disclaims any such beneficial ownership of securities not held of record by them. Ares Partners is managed by a board of managers, which is composed of Michael J Arougheti, R. Kipp deVeer, David B. Kaplan, Antony P. Ressler and Bennett Rosenthal (collectively, the "Board Members"). Mr. Ressler generally has veto authority over Board Members' decisions. Each of these individuals disclaims beneficial ownership of the securities that may be deemed to be beneficially owned by Ares Partners. |
Common Stock
(I)
|
23,000,000 |
| 2026-08-13 | ARES MANAGEMENT LLC |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
Following the transactions reported herein, includes 53,083,382 shares held by Ares Corporate Opportunities Fund V, L.P. ("ACOF V"), 5,435,262 shares held by ASSF IV AIV B Holdings III, L.P. ("ASSF IV AIV Holdings"), 7,945,865 shares held by ASSF IV AIV B, L.P. ("ASSF IV AIV") and 26,223,742 shares held by ASOF Holdings I, L.P. ("ASOF Holdings I"). Also includes 1,760,937 shares (the "Managed Shares") held by an account managed by ASSF Operating Manager IV, L.P. with respect to which the Ares Entities (as defined below) may be deemed to have shared voting or dispositive power. The Ares Entities disclaim beneficial ownership of the Managed Shares for purposes of Section 16 and this report shall not be deemed an admission that any of the Ares Entities are the beneficial owner of the Managed Shares for purposes of Section 16 or for any other purpose. Ares Partners Holdco LLC ("Ares Partners") is the sole member of each of Ares Voting LLC and Ares Management GP LLC, which are respectively the holders of the Class B and Class C common stock of Ares Management Corporation ("Ares Management"), which common stock allows them, collectively, to generally have the majority of the votes on any matter submitted to the stockholders of Ares Management if certain conditions are met. Ares Management is the sole member of Ares Holdco LLC, which is the general partner of Ares Management Holdings L.P., which is the sole member of Ares Management LLC, which is: (i) the sole member of ACOF Investment Management LLC, which is the manager of ACOF V; (ii) the general partner of ASSF Operating Manager IV, L.P., which is the manager of each of ASSF IV AIV Holdings and ASSF IV AIV; and (iii) the sole member of ASOF Investment Management LLC, which is the manager of ASOF Holdings I. We refer to all of the foregoing entities collectively as the Ares Entities Each of the Ares Entities may be deemed to share beneficial ownership of the securities reported herein, but each disclaims any such beneficial ownership of securities not held of record by them. Ares Partners is managed by a board of managers, which is composed of Michael J Arougheti, R. Kipp deVeer, David B. Kaplan, Antony P. Ressler and Bennett Rosenthal (collectively, the "Board Members"). Mr. Ressler generally has veto authority over Board Members' decisions. Each of these individuals disclaims beneficial ownership of the securities that may be deemed to be beneficially owned by Ares Partners. |
Common Stock
(I)
|
23,000,000 |
| 2026-08-11 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-11 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
42,059 |
| 2026-08-11 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-11 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
42,059 |
| 2026-08-11 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.72 to $12.15. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
92,059 |
| 2026-08-10 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-10 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-10 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.74 to $12.41. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
100,000 |
| 2026-08-10 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-10 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Convert↑
|
Common Stock
|
23,344 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. The total outstanding excludes the portion of the original option grant that was solely time-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
5,000 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-07 | Geisser Melinda L. |
Chief People Services Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
20,000 |
| 2026-08-07 | Geisser Melinda L. |
Chief People Services Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
15,000 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.05 to $12.05. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
13,036 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.05 to $12.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
13,062 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
15,000 |
| 2026-08-07 | Geisser Melinda L. |
Chief People Services Officer |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.07 to $12.63. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
36,964 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
15,000 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
23,344 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-07 | Maher Michael W |
CFO & Treasurer |
Convert↑
|
Common Stock
|
44,742 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-07 | Maher Michael W |
CFO & Treasurer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 2, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.00 to $12.65. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
44,742 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Convert↑
|
Common Stock
|
16,656 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.06 to $12.67. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
36,938 |
| 2026-08-07 | Maher Michael W |
CFO & Treasurer |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting conditions. Reflects an award of non-qualified stock options pursuant to the Savers Value Village Omnibus Incentive Compensation Plan that are scheduled to vest in approximately one-third increments on March 12, 2026, March 12, 2027 and March 12, 2028. |
Stock Options (Right to Purchase)
|
44,742 |
| 2026-08-07 | Geisser Melinda L. |
Chief People Services Officer |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
16,656 |
| 2026-08-07 | Geisser Melinda L. |
Chief People Services Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
15,000 |
| 2026-08-07 | Maher Michael W |
CFO & Treasurer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 2, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.00 to $12.61. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
5,000 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Convert↑
|
Common Stock
|
5,000 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
15,000 |
| 2026-08-06 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-06 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-06 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $10.3850 to $11.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
50,000 |
| 2026-08-06 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $10.50 to $11.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
50,000 |
| 2026-08-06 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |